News
Media
Medical World NewsPodcastsVideosInsightsPeer ExchangeMedia DayNews NetworkRoundtables
Conference
Conference CoverageConference Listing
Publication
More
CME/CE
Partners
Resources
Interactive ToolsSpecial ProjectsSponsored
Contribute
Case StudiesWriters and Mentors

Subscribe

  • News
  • Media
  • Conference
  • Publication
  • CME/CE
  • Partners
  • Resources
  • Contribute
  • Subscribe
  • Antimicrobial Stewardship
  • Blood-Borne Diseases
    • Ebola
    • HCV / Hepatitis
  • Coronavirus / COVID
  • Food Borne Infection / Food Safety
    • E. Coli
    • Food Safety
    • Listeria
    • Salmonella
  • Fungal Infections
    • Candida auris
  • Gastrointestinal Infections
    • C. Difficile
    • H. Pylori
    • Norovirus
  • Healthcare Associated Infections (HAI)
  • Prevention
    • Antibiotics
    • Immunizations
    • Vaccines
  • Respiratory Infections
    • Community-Acquired Pneumonia
    • Measles
    • Influenza
  • Sexually Transmitted Diseases
    • HIV / AIDS
    • HPV
    • HSV
    • PrEP
  • Skin & Soft Tissue Diseases
    • MRSA
  • Zoonotic & Vector-Borne Diseases
    • Lyme Disease
    • ZIKA
Spotlight -
Antimicrobial Stewardship|
Bench to Bedside With SIDP|
C. difficile |
Clinical Corner|
Fungal Infections|
Hepatitis|
RSV: A New Era in Prevention
Advertisement

Elias K. Manavathu, PhD

Advertisement

Articles by Elias K. Manavathu, PhD

Medical Importance of Microbial Biofilms in the Management of Infectious Diseases

ByJose A. Vazquez, MD,Elias K. Manavathu, PhD
February 26th 2020

Biofilms are an emerging clinical problem despite the fact that most clinicians don’t even think of biofilms when managing infections.

Advertisement

Latest Updated Articles

  • Medical Importance of Microbial Biofilms in the Management of Infectious Diseases
    Medical Importance of Microbial Biofilms in the Management of Infectious Diseases

    Published: February 26th 2020 | Updated:



Advertisement
Advertisement

Trending on Contagion Live

1

Single-Tablet Regimen of Bictegravir and Lenacapavir for HIV Meets Primary Endpoint in Phase 3 Study

2

Zoliflodacin Emerges as a First-in-Class Oral Option Against Drug-Resistant Gonorrhea

3

FDA Approves Zoliflodacin for Uncomplicated Urogenital Gonorrhea

4

Top Infectious Disease News Stories Week of December 6 - December 12

5

Caring Holistically: NYU’s Approach to Pediatric Infectious Disease

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us